1. 122: CORE: A randomised trial of COnventional care versus Radioablation (stereotactic body radiotherapy) for Extracranial oligometastases. (January 2017) Authors: Khoo, V.; Ahmed, M.; McDonald, F.; Kirby, A.; Van As, N.; Hawkins, M.; Syndikis, I.; Franks, K.; Jain, S.; Tree, A.; Eaton, D.; Patel, R.; Braidley, M. Yip; Kilburn, L.; Toms, C.; Hall, E. Journal: Lung cancer Issue: Volume 103(2017)Supplement 1 Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2507 Prognostic factors in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 trial (CRUK/01/004). (September 2015) Authors: Huddart, R.; Porta, N.; Lewis, R.; Hendron, C.; Hussein, S.; James, N.; Hall, E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2579 Evaluation of clinical decision-making and the use of circulating tumor cells (CTCs) by physicians treating castration-resistant prostate cancer (CRPC). (September 2015) Authors: Lorente, D.; Ravi, P.; Mehra, N.; Gillman, A.; Omlin, A.; Pezaro, C.; Miranda, M.; Mateo, J.; Rescigno, P.; Kolinsky, M.; Porta, N.; Jayaram, A.; Bianchini, D.; Hall, E.; Ijzerman, M.J.; De Bono, J.S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2642 The predictive and prognostic value of tumour necrosis in muscle invasive bladder cancer patients receiving radiotherapy with or without chemotherapy in the BC2001 (CRUK/01/004) trial. (September 2015) Authors: Ananya, C.; West, C.; Porta, N.; Denley, H.; Hendron, C.; Hussain, S.; Hall, E.; Huddart, R.; James, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 343 Translational phase I trial combining the AKT inhibitor AZD5363 (AZD) and PARP inhibitor Olaparib (Ola) in advanced cancer patients (pts). (September 2015) Authors: Michalarea, V.; Lopez, J.; Lorente, D.; Carreira, S.; Hassam, H.; Parmar, M.; Turner, A.; Hall, E.; Fandos, S. Serrano; Decordova, S.; Swales, K.; Ruddle, R.; Raynaud, F.; Tunariu, N.; Stephens, C.M.; Molife, L.R.; Banerji, U.; Plummer, R.; Bono, J. De; Yap, T.A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group. (September 2015) Authors: Dearnaley, D.; Syndikus, I.; Mossop, H.; Birtle, A.; Bloomfield, D.; Cruickshank, C.; Graham, J.; Hassan, S.; Khoo, V.; Logue, J.; Mayles, H.; Money-Kyrle, J.; Naismith, O.; Panades, M.; Patterson, H.; Scrase, C.; Staffurth, J.; Tremlett, J.; Griffin, C.; Hall, E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Randomised Trial of Conventional Care versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases. Issue 6 (June 2018) Authors: Khoo, V.; Hawkins, M.; Ahmed, M.; Kirby, A.; van As, N.; McDonald, F.; Franks, K.; Syndikus, I.; Jain, S.; Tree, A.; Patel, R.; Hall, E. Journal: Clinical oncology Issue: Volume 30:Issue 6(2018) Page Start: e64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER). Issue 6 (June 2021) Authors: Hafeez, S.; Lewis, R.; Hall, E.; Huddart, R.; Birtle, A.; Choudhury, A.; Cresswell, J.; Foroudi, F.; Gribble, H.; Griffin, C.; Hafeez, S.; Hall, E.; Hansen, V.H.; Henry, A.; Hindson, B.; Huddart, R.; Kron, T.; Kumar, P.; Lewis, R.; McLaren, D. Journal: Clinical oncology Issue: Volume 33:Issue 6(2021) Page Start: e251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. An audit to explore the efficient and effective use of MRI scans and referral pathways in a musculoskeletal interface service. (January 2019) Authors: Jeeves, B.; Ali, A.; Stevenson, K.; Menon, A.; Hall, E. Journal: Physiotherapy Issue: Volume 105(2019)Supplement 1 Page Start: e157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Burden of illness and costs among paediatric haemophilia patients with and without central venous access devices treated in US hospitals. Issue 3 (25th March 2018) Authors: Buckley, B.; Dreyfus, J.; Prasad, M.; Gayle, J.; Kendter, J.; Hall, E. Journal: Haemophilia Issue: Volume 24:Issue 3(2018) Page Start: e93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗